Northern Jiangsu People's Hospital
Clinical trials sponsored by Northern Jiangsu People's Hospital, explained in plain language.
-
Blood thinner apixaban tested for late clots after spleen surgery
Disease control Recruiting nowThis study tests whether the blood thinner apixaban can dissolve blood clots in the portal vein that develop more than a year after laparoscopic spleen surgery in people with cirrhosis. Twenty participants will take apixaban twice daily, and doctors will use ultrasound or CT scan…
Phase: NA • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a blood thinner clear stubborn clots after spleen surgery?
Disease control Recruiting nowThis study looks at whether the blood thinner apixaban can safely dissolve blood clots in the portal vein (the main vein to the liver) that appear more than a year after spleen removal surgery. It involves 20 adults with cirrhosis who had their spleen removed. The goal is to see …
Phase: NA • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New surgical technique aims to prevent stomach issues after spleen removal
Disease control Recruiting nowThis study tests a new surgical method that uses the vagus nerve to guide spleen removal and vein disconnection in people with cirrhosis and portal hypertension. The goal is to see if this nerve-guided approach reduces common post-surgery problems like diarrhea and delayed stomac…
Phase: NA • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could two steroids slash septic shock deaths?
Disease control Recruiting nowThis study tests whether giving two steroids—hydrocortisone and fludrocortisone—for up to 7 days can lower the risk of death in adults with septic shock. About 336 patients will be randomly assigned to receive either the steroid combo or standard care alone. The main goal is to s…
Phase: PHASE4 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Liver cancer patients get targeted chemo after surgery to stop return
Disease control Recruiting nowThis study tests whether giving a specific chemotherapy cocktail (mFOLFOX) directly into the liver artery after surgery can prevent liver cancer from coming back in patients at high risk. About 30 adults who had their liver cancer removed will receive up to two rounds of this inf…
Phase: PHASE2 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo aims to stop liver cancer recurrence in High-Risk patients
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of Icaritin soft capsules and a liver-directed chemotherapy infusion (mFOLFOX) can prevent hepatocellular carcinoma from coming back after surgery in patients with high-risk features. About 30 participants will receive the treat…
Phase: PHASE2 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo before lung surgery shows promise in early trial
Disease control Recruiting nowThis phase II trial is testing whether giving the immunotherapy drug tislelizumab along with radiation therapy before surgery can help eliminate more cancer in people with resectable non-small cell lung cancer (NSCLC). About 20 participants will receive the combination, then have…
Phase: PHASE2 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Partial spleen removal may boost immunity in liver cirrhosis patients
Disease control Recruiting nowThis study looks at whether removing only part of the spleen (instead of the whole spleen) can improve immune function in people with liver cirrhosis who have an overactive spleen (hypersplenism). About 30 adults will be enrolled. Researchers will measure immune markers and blood…
Phase: NA • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Scientists probe stomach paralysis in diabetes
Knowledge-focused Recruiting nowThis study looks at why people with diabetes develop gastroparesis, a condition where the stomach doesn't empty properly. Researchers will collect blood and stomach tissue samples from 50 participants to examine how certain molecules affect stomach muscle function. The goal is to…
Sponsor: Northern Jiangsu People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC